COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,864 Articles (22,568 medRxiv, 8,296 bioRxiv)

Most recent first Previous |  Page 2752: Articles 27511-27520  | Next

The confounded crude case-fatality rates for COVID-19 hide more than they reveal - a comparison of age-specific and age-adjusted rates between six countries
Green, M. S., Peer, V., Nitzan, D.
10.1101/2020.05.09.20096503 — Posted: 2020-05-13
Three pictures of COVID-19 behavior in Italy: similar growth and different degrowth
Feoli, A., Iannella, A. L., Benedetto, E.
10.1101/2020.05.09.20096149 — Posted: 2020-05-13 Discussion: Onsite
Monitoring the propagation of COVID-19-pandemic first waves
Knafo, W.
10.1101/2020.05.09.20096768 — Posted: 2020-05-13
Systemic hypoferraemia and severity of hypoxaemic respiratory failure in COVID-19
Shah, A., Frost, J., Aaron, L., Donovan, K., McKechnie, S., Stanworth, S., Drakesmith, H.
10.1101/2020.05.11.20092114 — Posted: 2020-05-13
Association of Vitamin D Deficiency and Treatment with COVID-19 Incidence
Meltzer, D. O., Best, T. J., Zhang, H., Vokes, T., Arora, V., Solway, J.
10.1101/2020.05.08.20095893 — Posted: 2020-05-13 Discussion: Onsite
Serum protein profiling reveals a landscape of inflammation and immune signaling in early-stage COVID-19 infection
Hou, X., Zhang, X., Wu, X., Lu, M., Wang, D., Xu, M., Wang, H., Dai, J., Duan, H., Xu, Y., Yu, X., Li, Y.
10.1101/2020.05.08.20095836 — Posted: 2020-05-13 Discussion: Onsite
A Novel Box for Aerosol and Droplet Guarding and Evacuation in Respiratory Infection (BADGER): A Potential Mitigating Strategy for the COVID-19 Pandemic and Future Outbreaks
Le, H. D., Novak, G. A., Janek, K. C., Wang, J., Huynh, K. N., Meyer, C., Weinstein, A., Oberstar, E., Rasmussen, J., Bertram, T.
10.1101/2020.05.09.20096032 — Posted: 2020-05-13
SARS-CoV-2 activates lung epithelia cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients by single-cell sequencing
Chen, H., Liu, W., Liu, D., Zhao, L., Yu, J.
10.1101/2020.05.08.20096024 — Posted: 2020-05-13 Discussion: Onsite | Offsite
Saliva as a non-invasive sample for the detection of SARS-CoV-2: a systematic review
Khurshid, Z., Zohaib, S., Joshi, C., Moin, S. F., Zafar, M. S., Speicher, D. J.
10.1101/2020.05.09.20096354 — Posted: 2020-05-13
Higher Air Temperature, Pressure, and Ultraviolet Are Associated with Less Covid-19 Incidence
Takagi, H., Kuno, T., Yokoyama, Y., Ueyama, H., Matsushiro, T., Hari, Y., Ando, T.
10.1101/2020.05.09.20096321 — Posted: 2020-05-13 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).